The roles of mouse double minute 2 (MDM2) oncoprotein in ocular diseases: A review

H Jiang, J Luo, H Lei - Experimental Eye Research, 2022 - Elsevier
Abstract Mouse double minute 2 (MDM2), an E3 ubiquitin ligase and the primary negative
regulator of the tumor suppressor p53, cooperates with its structural homolog MDM4/MDMX …

Biomarkers in the occurrence and development of pterygium

S He, Z Wu - Ophthalmic Research, 2022 - karger.com
Pterygium is a kind of common conjunctival degeneration. The pathogenesis of pterygium is
complex, and various biomarkers provide new targets for treatment and prognosis …

A review of management strategies for nociceptive and neuropathic ocular surface pain

H Dermer, D Lent-Schochet, D Theotoka, C Paba… - Drugs, 2020 - Springer
Despite being a common presenting symptom to eye-care clinics, many ophthalmologists
have difficulty diagnosing and managing ocular surface pain. The purpose of this review is …

Efficacy of bevacizumab in the treatment of pterygium: An updated meta-analysis of randomized controlled trials

X Zhang, Y Jiang, Q Fu, X Zhang, Y Chen - International …, 2021 - Elsevier
Recurrence is the most common problem following pterygium surgery. Whether
bevacizumab can prevent pterygium recurrence is controversial. To address this point, we …

Fifteen-year results of a randomized controlled trial comparing 0.02% mitomycin C, limbal conjunctival autograft, and combined mitomycin C with limbal conjunctival …

KW Kam, AL Young - Graefe's Archive for Clinical and Experimental …, 2019 - Springer
Purpose To compare the long-term outcomes of recurrent pterygium surgery between three
different techniques. Methods We performed a 15-year follow-up study of a randomized …

[HTML][HTML] Pterygium: surgical techniques and choices

AL Young, KW Kam - The Asia-Pacific Journal of Ophthalmology, 2019 - journals.lww.com
Pterygium is known to exist for> 3000 years. Ancient Egyptians and Greeks applied potions
of various chemicals to the ocular surface as an attempt to eradicate the lesion. The first …

Targeted delivery of mitomycin C-loaded and LDL-conjugated mesoporous silica nanoparticles for inhibiting the proliferation of pterygium subconjunctival fibroblasts

M Wu, S Wang, Y Wang, F Zhang, T Shao - Experimental Eye Research, 2020 - Elsevier
Pterygium is a degenerative disease that characterized by excessive fibrovascular
proliferation. To reduce the recurrence rate, surgery is the main strategy, in combination with …

Canonical phospholipase D isoforms in visual function and ocular response to stress

V Bermúdez, PE Tenconi, NM Giusto… - Experimental Eye …, 2022 - Elsevier
Highlights•Through the generation of PA and DAG, PLDs can modulate several cellular
events.•We summarize the role of PLDs in physiological and pathological responses in the …

Pterigión: conceptos y manejo actual

EC Barrantes, AC Espinoza - Revista Médica Sinergia, 2021 - dialnet.unirioja.es
El pterigión es una de las patologías oculares más comunes que se presentan en la
consulta diaria de oftalmología. Es por la frecuente presencia de esta patología, en la …

Surgical Time and Postoperative Symptoms Study in Pterygium Excision and Amniotic Membrane Graft Using Celularity Triple Layer Dehydrated Amniotic Membrane

P Rivera-Morales, L Barnard, W Linderman… - Clinical …, 2023 - Taylor & Francis
Purpose To evaluate a novel sutureless glueless technique using a triple-layer dehydrated
amniotic membrane (TLDAM) for pterygia excisions in surgical time, postoperative pain …